Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
Titel:
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
Auteur:
Petrylak, Daniel P de Wit, Ronald Chi, Kim N Drakaki, Alexandra Sternberg, Cora N Nishiyama, Hiroyuki Castellano, Daniel Hussain, Syed A Fléchon, Aude Bamias, Aristotelis Yu, Evan Y van der Heijden, Michiel S Matsubara, Nobuaki Alekseev, Boris Necchi, Andrea Géczi, Lajos Ou, Yen-Chuan Coskun, Hasan Senol Su, Wen-Pin Bedke, Jens Gakis, Georgios Percent, Ivor J Lee, Jae-Lyun Tucci, Marcello Semenov, Andrey Laestadius, Fredrik Peer, Avivit Tortora, Giampaolo Safina, Sufia Garcia del Muro, Xavier Rodriguez-Vida, Alejo Cicin, Irfan Harputluoglu, Hakan Tagawa, Scott T Vaishampayan, Ulka Aragon-Ching, Jeanny B Hamid, Oday Liepa, Astra M Wijayawardana, Sameera Russo, Francesca Walgren, Richard A Zimmermann, Annamaria H Hozak, Rebecca R Bell-McGuinn, Katherine M Powles, Thomas